University of Minnesota - LifeScience Alley Breakthrough Series

October 29, 2007
Continuing Education and Conference Center, St. Paul Campus

An Office of Clinical Research – LifeScience Alley Breakthrough Series Event

The topic of this Breakthrough Series event is Diabetes, presenting important academic and industry research into treatment using insulin delivery systems, continuous glucose monitoring, islet transplantation, stem cells, and other emerging modalities. Fifteen leading researchers and speakers from the University of Minnesota and industry are confirmed for this full-day program.

Breakthrough technology calls for Breakthrough collaboration between the University of Minnesota and the member organizations of LifeScience Alley. LifeScience Alley has joined with the Office of Clinical Research at the University of Minnesota to launch this educational partnership. This program – and all in the series – will be highly interactive. Presentations and panel discussions will add intellectual depth to our understanding of current and future research directions, and will look at emerging interventions from many perspectives. Question-and-answer periods will give everyone opportunities to interact with presenters and with each other. There will be extensive networking opportunities among academic researchers, industry representatives, physicians, insurers, regulatory and clinical professionals, and investors. The purpose here is to enhance Minnesota-based leadership in new technology.

MONDAY – October 29, 2007

Diabetes meets the new technology:

7:00                  Registration and breakfast/coffee

8:00-8:15           Welcome and Opening remarks: Jasit Ahluwalia, MD, MPH, MS and
                          Russell Luepker, MD, MS; Elizabeth Seaquist, MD and Larry
                          Kuusisto, PhD

8:15-8:45           Diabetes:  What is the scope of the problem?
                          Elizabeth Seaquist, MD (view presentation)
                          Prevalence/incidence; demographics; societal impact; the
                          clinical picture

8:45-9:15           Targeting Glucose Metabolism to Improve Treatment of Type 2
                          Diabetes
                          Alex Lange, PhD (view presentation)
                       
9:15-9:30    BREAK

9:30-11:15         Continuous Glucose Monitoring
9:30-10:00         Novel methods to measure interstitial glucose: Ronald Siegel, ScD (view presentation)
10:00-10:30       Medtronic Diabetes: Claudia Graham, VP (view presentation)
10:30-11:00       International Diabetes Center:  Roger Mazze, PhD
11:00-11:30       Panel discussion Q & A

11:30-Noon        University of Minnesota – New Technologies and Business
                          Advancement
                          Institute for Engineering in Medicine: Arthur Erdman, PhD (view presentation)
                          Medical Industry Leadership Institute: Stephen Parente, PhD (view presentation)

Noon-1:00    LUNCH                              

1:00-2:30           Islet Cell Transplantation  - Xenotransplantation
1:00-1:30           Using pig islets in primates:  Bernhard Hering, MD
1:30-2:00           Where do the pigs come from?  Henk-Jan Schuurman, PhD (view presentation)
2:00-2:30           Ethics of xenotransplantation:  Jeffrey Kahn, PhD, MPH (view presentation)

2:30-2:45    BREAK

2:45-4:14           Novel Approaches to Diabetes Treatment & Prevention:
2:45-3:15           Use of embryonic stem cells:  Meri Firpo, PhD
3:15-3:45           Use of pancreatic stem cells:  Jonathan Slack, PhD (view presentation)
3:45-4:15           Is Type 2 Diabetes a binge-eating disorder?  Scott Crow, MD (view presentation)

4:15-5:15           The Next Steps – Advancing our Med-Tech Edge
                          Panel – problem solving discussions
                          Audience Q&A

5:15-6:00           Networking Reception

Office of Clinical Research – LifeScience Alley Breakthrough Series. The purpose of this continuing series is to spotlight University of Minnesota research and to effectively connect the University with the medical technology industry and healthcare. LifeScience Alley with its more than 500 industry-wide member organizations is unmatched anywhere in the country. We have a unique opportunity here to link world-class research with world-class medical technology, and we intend to build, strengthen, and sustain strong effective relationships.

This Breakthrough series will highlight breakthroughs in health and breakthroughs in collaboration. The University’s Office of Clinical Research and LifeScience Alley intend to create an unparalleled model of academic-industry cooperation